Medical Care

Global Insomnia Therapy Market Research Report 2025

The global market for Insomnia Therapy was valued at US$ 3060 million in the year 2024 and is projected to reach a revised size of US$ 4342 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Insomnia is when you aren"t sleeping as you should. That can mean you aren"t sleeping enough, you aren"t sleeping well or you"re having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
This report aims to provide a comprehensive presentation of the global market for Insomnia Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapy.
The Insomnia Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insomnia Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2020-2031)
2.2 Global Insomnia Therapy Growth Trends by Region
2.2.1 Global Insomnia Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Insomnia Therapy Historic Market Size by Region (2020-2025)
2.2.3 Insomnia Therapy Forecasted Market Size by Region (2026-2031)
2.3 Insomnia Therapy Market Dynamics
2.3.1 Insomnia Therapy Industry Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Revenue
3.1.1 Global Top Insomnia Therapy Players by Revenue (2020-2025)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2024
3.5 Global Key Players of Insomnia Therapy Head office and Area Served
3.6 Global Key Players of Insomnia Therapy, Product and Application
3.7 Global Key Players of Insomnia Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2020-2025)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2026-2031)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2020-2025)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Insomnia Therapy Market Size (2020-2031)
6.2 North America Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Insomnia Therapy Market Size by Country (2020-2025)
6.4 North America Insomnia Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2020-2031)
7.2 Europe Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Insomnia Therapy Market Size by Country (2020-2025)
7.4 Europe Insomnia Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size (2020-2031)
8.2 Asia-Pacific Insomnia Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Insomnia Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Insomnia Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapy Market Size (2020-2031)
9.2 Latin America Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Insomnia Therapy Market Size by Country (2020-2025)
9.4 Latin America Insomnia Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size (2020-2031)
10.2 Middle East & Africa Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Insomnia Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Insomnia Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2020-2025)
11.1.5 Merck & Co. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2020-2025)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Details
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2020-2025)
11.5.5 Purdue Pharmaceuticals L.P. Recent Development
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Details
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2020-2025)
11.6.5 Eisai, Co. Ltd. Recent Development
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Details
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2020-2025)
11.7.5 Meda Consumer Healthcare Recent Development
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2020-2025)
11.8.5 Pernix Therapeutics Recent Development
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Details
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025)
11.9.5 Vanda Pharmaceuticals Recent Development
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Details
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025)
11.10.5 ECR Pharmaceuticals Recent Development
11.11 Fidia Farmaceutici
11.11.1 Fidia Farmaceutici Company Details
11.11.2 Fidia Farmaceutici Business Overview
11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2020-2025)
11.11.5 Fidia Farmaceutici Recent Development
11.12 Dainippon Sumitomo
11.12.1 Dainippon Sumitomo Company Details
11.12.2 Dainippon Sumitomo Business Overview
11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2020-2025)
11.12.5 Dainippon Sumitomo Recent Development
11.13 Biocodex
11.13.1 Biocodex Company Details
11.13.2 Biocodex Business Overview
11.13.3 Biocodex Insomnia Therapy Introduction
11.13.4 Biocodex Revenue in Insomnia Therapy Business (2020-2025)
11.13.5 Biocodex Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Insomnia Therapy Introduction
11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2020-2025)
11.14.5 Eli Lilly and Company Recent Development
11.15 Ebb Therapeutics
11.15.1 Ebb Therapeutics Company Details
11.15.2 Ebb Therapeutics Business Overview
11.15.3 Ebb Therapeutics Insomnia Therapy Introduction
11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2020-2025)
11.15.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-pharmacological Therapy
Table 3. Key Players of Pharmacological Therapy
Table 4. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Insomnia Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Insomnia Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Insomnia Therapy Market Share by Region (2020-2025)
Table 8. Global Insomnia Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Insomnia Therapy Market Share by Region (2026-2031)
Table 10. Insomnia Therapy Market Trends
Table 11. Insomnia Therapy Market Drivers
Table 12. Insomnia Therapy Market Challenges
Table 13. Insomnia Therapy Market Restraints
Table 14. Global Insomnia Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Insomnia Therapy Market Share by Players (2020-2025)
Table 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2024)
Table 17. Ranking of Global Top Insomnia Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Insomnia Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Insomnia Therapy, Headquarters and Area Served
Table 20. Global Key Players of Insomnia Therapy, Product and Application
Table 21. Global Key Players of Insomnia Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Insomnia Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Insomnia Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Insomnia Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Insomnia Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Insomnia Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Insomnia Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Insomnia Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Insomnia Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Insomnia Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Insomnia Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck & Co. Company Details
Table 47. Merck & Co. Business Overview
Table 48. Merck & Co. Insomnia Therapy Product
Table 49. Merck & Co. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 50. Merck & Co. Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Insomnia Therapy Product
Table 54. Sanofi Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Insomnia Therapy Product
Table 59. Pfizer Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Takeda Pharmaceutical Company Ltd. Company Details
Table 62. Takeda Pharmaceutical Company Ltd. Business Overview
Table 63. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
Table 64. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 65. Takeda Pharmaceutical Company Ltd. Recent Development
Table 66. Purdue Pharmaceuticals L.P. Company Details
Table 67. Purdue Pharmaceuticals L.P. Business Overview
Table 68. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
Table 69. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 70. Purdue Pharmaceuticals L.P. Recent Development
Table 71. Eisai, Co. Ltd. Company Details
Table 72. Eisai, Co. Ltd. Business Overview
Table 73. Eisai, Co. Ltd. Insomnia Therapy Product
Table 74. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 75. Eisai, Co. Ltd. Recent Development
Table 76. Meda Consumer Healthcare Company Details
Table 77. Meda Consumer Healthcare Business Overview
Table 78. Meda Consumer Healthcare Insomnia Therapy Product
Table 79. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 80. Meda Consumer Healthcare Recent Development
Table 81. Pernix Therapeutics Company Details
Table 82. Pernix Therapeutics Business Overview
Table 83. Pernix Therapeutics Insomnia Therapy Product
Table 84. Pernix Therapeutics Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 85. Pernix Therapeutics Recent Development
Table 86. Vanda Pharmaceuticals Company Details
Table 87. Vanda Pharmaceuticals Business Overview
Table 88. Vanda Pharmaceuticals Insomnia Therapy Product
Table 89. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 90. Vanda Pharmaceuticals Recent Development
Table 91. ECR Pharmaceuticals Company Details
Table 92. ECR Pharmaceuticals Business Overview
Table 93. ECR Pharmaceuticals Insomnia Therapy Product
Table 94. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 95. ECR Pharmaceuticals Recent Development
Table 96. Fidia Farmaceutici Company Details
Table 97. Fidia Farmaceutici Business Overview
Table 98. Fidia Farmaceutici Insomnia Therapy Product
Table 99. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 100. Fidia Farmaceutici Recent Development
Table 101. Dainippon Sumitomo Company Details
Table 102. Dainippon Sumitomo Business Overview
Table 103. Dainippon Sumitomo Insomnia Therapy Product
Table 104. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 105. Dainippon Sumitomo Recent Development
Table 106. Biocodex Company Details
Table 107. Biocodex Business Overview
Table 108. Biocodex Insomnia Therapy Product
Table 109. Biocodex Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 110. Biocodex Recent Development
Table 111. Eli Lilly and Company Company Details
Table 112. Eli Lilly and Company Business Overview
Table 113. Eli Lilly and Company Insomnia Therapy Product
Table 114. Eli Lilly and Company Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 115. Eli Lilly and Company Recent Development
Table 116. Ebb Therapeutics Company Details
Table 117. Ebb Therapeutics Business Overview
Table 118. Ebb Therapeutics Insomnia Therapy Product
Table 119. Ebb Therapeutics Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)
Table 120. Ebb Therapeutics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report


List of Figures
Figure 1. Insomnia Therapy Picture
Figure 2. Global Insomnia Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Insomnia Therapy Market Share by Type: 2024 VS 2031
Figure 4. Non-pharmacological Therapy Features
Figure 5. Pharmacological Therapy Features
Figure 6. Global Insomnia Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Insomnia Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Insomnia Therapy Report Years Considered
Figure 12. Global Insomnia Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Insomnia Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Insomnia Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Insomnia Therapy Market Share by Players in 2024
Figure 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2024
Figure 18. North America Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Insomnia Therapy Market Share by Country (2020-2031)
Figure 20. United States Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Insomnia Therapy Market Share by Country (2020-2031)
Figure 24. Germany Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Insomnia Therapy Market Share by Region (2020-2031)
Figure 32. China Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Insomnia Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Insomnia Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 48. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 50. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 51. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 52. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 53. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 54. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 55. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 56. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 57. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 58. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 59. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 61. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies